PMID- 15572660 OWN - NLM STAT- MEDLINE DCOM- 20041230 LR - 20201209 IS - 0270-7306 (Print) IS - 1098-5549 (Electronic) IS - 0270-7306 (Linking) VI - 24 IP - 24 DP - 2004 Dec TI - A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. PG - 10515-28 AB - We identified Ras guanine-releasing protein 3 (RasGRP3) as a guanine exchange factor expressed in blood vessels via an embryonic stem (ES) cell-based gene trap screen to identify novel vascular genes. RasGRP3 is expressed in embryonic blood vessels, down-regulated in mature adult vessels, and reexpressed in newly formed vessels during pregnancy and tumorigenesis. This expression pattern is consistent with an angiogenic function for RasGRP3. Although a loss-of-function mutation in RasGRP3 did not affect viability, RasGRP3 was up-regulated in response to vascular endothelial growth factor (VEGF) stimulation of human umbilical vein endothelial cells, placing RasGRP3 regulation downstream of VEGF signaling. Phorbol esters mimic the second messenger diacylglycerol (DAG) in activating both protein kinase C (PKC) and non-PKC phorbol ester receptors such as RasGRP3. ES cell-derived wild-type blood vessels exposed to phorbol myristate acetate (PMA) underwent extensive aberrant morphogenesis that resulted in the formation of large endothelial sheets rather than properly branched vessels. This response to PMA was completely dependent on the presence of RasGRP3, as mutant vessels were refractory to the treatment. Taken together, these findings show that endothelial RasGRP3 is up-regulated in response to VEGF stimulation and that RasGRP3 functions as an endothelial cell phorbol ester receptor in a pathway whose stimulation perturbs normal angiogenesis. This suggests that RasGRP3 activity may exacerbate vascular complications in diseases characterized by excess DAG, such as diabetes. FAU - Roberts, David M AU - Roberts DM AD - Curriculum in Genetics and Molecular Biology, Department of Biology, CB#3280, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. FAU - Anderson, Amanda L AU - Anderson AL FAU - Hidaka, Michihiro AU - Hidaka M FAU - Swetenburg, Raymond L AU - Swetenburg RL FAU - Patterson, Cam AU - Patterson C FAU - Stanford, William L AU - Stanford WL FAU - Bautch, Victoria L AU - Bautch VL LA - eng GR - R01 HL043174/HL/NHLBI NIH HHS/United States GR - R21 HL071993/HL/NHLBI NIH HHS/United States GR - HL 43174/HL/NHLBI NIH HHS/United States GR - HL 71993/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Guanine Nucleotide Exchange Factors) RN - 0 (Phorbol Esters) RN - 0 (RASGRP3 protein, human) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (ras Guanine Nucleotide Exchange Factors) RN - EC 2.7.1.107 (Diacylglycerol Kinase) RN - EC 2.7.11.13 (Protein Kinase C) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Amino Acid Sequence MH - Animals MH - Cell Line MH - Chromosome Mapping MH - Diacylglycerol Kinase/metabolism MH - Endothelium, Vascular/drug effects/*metabolism MH - Female MH - *Gene Expression Regulation, Developmental MH - Genetic Vectors MH - Guanine Nucleotide Exchange Factors/chemistry/genetics/*metabolism MH - Humans MH - Mice MH - Models, Biological MH - Molecular Sequence Data MH - Neovascularization, Physiologic/*drug effects MH - Phorbol Esters/metabolism/*pharmacology MH - Pregnancy MH - Protein Kinase C/metabolism MH - Protein Structure, Tertiary MH - Sequence Homology, Amino Acid MH - Signal Transduction MH - Stem Cells/cytology/drug effects MH - Tetradecanoylphorbol Acetate/pharmacology MH - Umbilical Veins/cytology MH - Up-Regulation MH - Vascular Endothelial Growth Factor A/metabolism MH - ras Guanine Nucleotide Exchange Factors PMC - PMC533983 EDAT- 2004/12/02 09:00 MHDA- 2004/12/31 09:00 PMCR- 2004/12/01 CRDT- 2004/12/02 09:00 PHST- 2004/12/02 09:00 [pubmed] PHST- 2004/12/31 09:00 [medline] PHST- 2004/12/02 09:00 [entrez] PHST- 2004/12/01 00:00 [pmc-release] AID - 24/24/10515 [pii] AID - 1229-04 [pii] AID - 10.1128/MCB.24.24.10515-10528.2004 [doi] PST - ppublish SO - Mol Cell Biol. 2004 Dec;24(24):10515-28. doi: 10.1128/MCB.24.24.10515-10528.2004.